5324752025-04-012025-06-305324752025-06-305324752025-04-012025-06-30in-capmkt:OtherExpenses1Member5324752025-04-012025-06-30in-capmkt:ReportableSegments1Member5324752025-04-012025-06-30in-capmkt:ReportableSegments2Member5324752025-04-012025-06-30in-capmkt:ReportableSegments3Member5324752025-04-012025-06-30in-capmkt:ReportableSegments1Member5324752025-04-012025-06-30in-capmkt:ReportableSegments2Member5324752025-04-012025-06-30in-capmkt:ReportableSegments3Member5324752025-04-012025-06-30in-capmkt:ReportableSegments1Member5324752025-06-30in-capmkt:ReportableSegments1Member5324752025-04-012025-06-30in-capmkt:ReportableSegments2Member5324752025-06-30in-capmkt:ReportableSegments2Member5324752025-04-012025-06-30in-capmkt:ReportableSegments3Member5324752025-06-30in-capmkt:ReportableSegments3Member5324752025-04-012025-06-30in-capmkt:ReportableSegments1Member5324752025-06-30in-capmkt:ReportableSegments1Member5324752025-04-012025-06-30in-capmkt:ReportableSegments2Member5324752025-06-30in-capmkt:ReportableSegments2Member5324752025-04-012025-06-30in-capmkt:ReportableSegments3Member5324752025-06-30in-capmkt:ReportableSegments3Member5324752025-04-012025-06-30ItemsThatWillNotBeReclassifiedToProfitAndLoss15324752025-04-012025-06-30ItemsThatWillNotBeReclassifiedToProfitAndLoss2iso4217:INRxbrli:pureiso4217:INRxbrli:shares532475APTECHTNAINE266F01018APTECH LIMITEDMain BoardEquity2025-04-012026-03-312025-08-042025-07-30INRLakhsQuarterlyFirst quarterMulti segment2025-08-0412:30:002025-08-0413:40:00Not applicable2025-04-012025-06-30UnauditedConsolidated120429100048525000125281600006850000-1281000180007000437900020237000945459000115565100097165000-19990009516600029626000-174600027880000067286000000067286000-1520000657660000000580017000101.161.16001.161.16000Notes : <BR> <BR> 1. The above Unaudited Consolidated Financial Results for the quarter ended June 30, 2025 have been reviewed by the Audit Committee and approved by the Board of Directors of the Company at their respective meetings held on August 4, 2025. The Consolidated Financial Results of the Company have been prepared in accordance with the Indian Accounting Standards (Ind AS) as prescribed under Section 133 of the Companies Act, 2013 read with relevant rules issued thereunder and the other accounting principles generally accepted in India. The Unaudited Consolidated Financial Results for the quarter ended June 30, 2025 have been subjected to limited review by the Statutory Auditors of the Company. <BR> <BR> 2. In the wake of Nigerian central bank removing trading restrictions on the official market, resulted in the Nigerian currency (Naira) dropping to a record low level, leading to foreign exchange loss of Rs. 19.99 lakhs (for the quarter ended June 20,2024 Rs. 50.07 lakhs) on restating Bank balances and Trade Receivables for the quarter ended June 30, 2025. The drop in currency prices being of exceptional nature, the resulting loss is reflected as an exceptional item during the quarter). <BR> <BR> 3. On a standalone basis, Aptech Limited has reported the following figures in its results for the quarter ended June 30, 2025: <BR> a. Revenue from Operations of Rs. 6,676.29 lakhs. <BR> b. Profit / (Loss) before tax of Rs. 842.54 lakhs. <BR> c. Profit / (Loss) after tax of Rs. 587.40 lakhs. <BR> <BR> 4. The figures for the quarter ended March 31, 2025 are the balancing figures between audited figures in respect of the full financial year and the unaudited published year-to-date figures upto the end of the third quarter of the relevant financial years. <BR> <BR> 5. The figures for the previous year has been regrouped/ rearranged/reclassified wherever necessary to correspond with figures of current year.Other Expenses945459000Retail974751000Institutional229540000Exceptional item0120429100001204291000Retail138673000Institutional9100000Exceptional item-199900014577400011070004950100095166000Retail1020226000Institutional513433000Exceptional item0153365900025297720004063431000Retail1214330000Institutional282852000Exceptional item014971820002479220001745104000Gain/ Loss) on Remeasument of Defined Benefit Plan-2964000Gain / (Loss) on Fair Valuation of Equity Instruments600000-2364000-8440000-1520000